Tumor budding is a prognostic factor in head and neck squamous cell carcinoma: A comprehensive meta-analysis and trial sequential analysis

Background: Mortality is linked to tumor budding (TB) in certain neoplasms. TB as a relevant histopathological feature is conditioned by tumor site, a specific study on head and neck squamous cell carcinoma (HNSCC) is needed. Methods: A comprehensive meta-analysis was undertaken to investigate the relationship between TB and HNSCC-related outcomes. Results: Overall 42 studies were included. Patients harboring high TB reported an Overall Survival (OS) Hazard Ratio (HR) of 2.63 (95% confidential interval (CI) 2.04–3.39; p-value < 0.001), Disease-free Survival (DFS) HR of 1.88 (95%CI 1.57–2.24; p-value <0.001) and Disease-specific Survival (DSS) HR of 2.14 (95%CI 1.81–2.52; p-value <0.001). Lymph Node Metastasis (LNM) studies harbored null heterogeneity and marked association with TB (Odds Ratio (OR) = 4.48, 95%CI 2.97–6.76; p-value < 0.001). Trial Sequential Analysis (TSA) supported definitive results for DSS. Conclusion: The study has provided compelling evidence that there is a significant association between TB and a worse prognosis for HNSCC.